维普中文期刊产品整合服务
21篇 您的检索式:作者名="Helenowski I"
    题名 作者 年代 出处 被引量
1Lipoprotein associated phospholipase A2 inhibition reduces generation of oxidized fatty acids:Lp-LPA2 reduces oxidized fatty acids显示文摘Rosenson RS Vracar-Grabar M Helenowski I 2008Cardiovasc Drugs Ther2008,22,1:1
2Lipoprotein associated phospholipase A2 inhibition reduces generation of oxidized fatty acids:LpLPA2 reduces oxidized fatty acids显示文摘Rosenson R S Vracar-Grabar M Helenowski I 0,,01:1
3Muhicenter analysis of 80 solid organ transplantation recipients with post- transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era显示文摘Evens AM David KA Helenowski I 2010J Clin Oneol2010,28,6:1
4A phase I / 1I trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas 显示文摘Evens AM Rosen ST Helenowski I 2013Br J Haematol2013,163,1:1
5A phaseⅠ/Ⅱtrial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas显示文摘Evens AM Rosen ST Helenowski I 2013Br J Haematol2013,163,:1
6Lipoprotein-associated phospholipase A2 inhibition reduces generation of oxidized fatty acids,LP-PLA2 reduces oxidized fatty acids显示文摘Rosenson RS Vracar-Grabar M Helenowski I 0,,:1
7Radical hysterectomy compared with primary radiation for treatment of stage 1B1 cervix cancer显示文摘Doll KM Donnelly E Helenowski I 2014Am J Clin Oneol2014,37,1:1
8Lipoprotein associated phospholipase A2 inhibition reduces generation of oxidized fatty acids:LP-PLA2 reduces oxidizd fatty acids显示文摘Resenson RS Vracar-Grabar M Helenowski I 2008Cardiovasc drugs Ther2008,22,:1
9CD23 +mantle cell lymphoma: a clinical pathologic entity associ-ated with superior outcome compared with CD23- disease显示文摘Kelemen K Peterson L C Helenowski I 2008Am J Clin Pathol2008,130,2:1
10Dosimetry and toxicity outcomes in postoperative high-dose-rate intracavit- ary brachytherapy for endometrial carcinoma显示文摘Donnelly ED Rakhra S Helenowski I 2012J Contemp Braehytherapy2012,4,3:1
11Lipoprotein associated phospholipase A2 reduces oxidized fatty acids 显示文摘ROSENSON R S VRACAR G M HELENOWSKI I 2008Cardiovasc Drugs Ther2008,22,1:1
12Analysis of very elderly ( 80 years )non-hodgkin lymphoma :impact of func- tional status and co-morbidities on outcome 显示文摘Nabhan C Smith SM Helenowski I 2012Br J Haema- to12012,156,2:1
13Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease:Outcomes and prognostic factors in the modem era显示文摘Evens AM David KA Helenowski I 2010J Clin Oncol2010,28,6:1
14Dosimetry and toxicity outcomes in postoperative high-dose-rate int- racavitary brachytherapy for endometrial carcinoma显示文摘Donnelly ED Rakhra S Helenowski I 2012J Contemp Brachytherapy2012,4,3:1
15Analysis of very elderly (≥80 years)non-hodgkin lymphoma:impact of functional status and co-morbidities on outcome显示文摘Nabhan C Smith SM Helenowski I 0,,02:1
16Lipoprotein associ- ated phospholipase A2 inhibition reduces generation of oxidized fat- ty acids: Lp-LPA2 reduces oxidized fatty acids显示文摘Rosenson R S Vracar-Grabar M Helenowski I 2008Cardiovasc Drugs Ther2008,22,1:1
17Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era显示文摘Evens AM David KA Helenowski I Nelson B Kaufman D Kircher SM 2010J CIin Oncol2010,28,6:1
18Lipoprotein as- sociated phospholipase A2 reducies oxidized fatty acides 显示文摘Rosenson RS Vracar GM Helenowski I 2008Cardiovasc Drugs Ther2008,22,:1
19Lipoprotein-associated phospholipase A2 reduces oxidized fatty acides显示文摘ROSENSON RS VRACAR GM HELENOWSKI I 2008Cardiovasc Drugs Ther2008,22,:1
20Management of adenocarcinoma in situ of the uterine cervix: a comparison of loop electrosurgical excision procedure and cold knife coniza- tion显示文摘Latif NA Neubauer NL Helenowski I B 2015Journal of Lower Genital Tract Disease2015,19,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费